Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000899923-25-000112
Filing Date
2025-11-04
Accepted
2025-11-04 06:18:47
Documents
76
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mygn-20250930.htm   iXBRL 10-Q 1039670
2 EX-10.4 ex104myriadwheeler-employm.htm EX-10.4 63362
3 EX-31.1 exhibit311-certificationof.htm EX-31.1 10295
4 EX-31.2 exhibit312-certificationof.htm EX-31.2 10290
5 EX-32.1 exhibit321-certificationpu.htm EX-32.1 6026
  Complete submission text file 0000899923-25-000112.txt   5677918

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mygn-20250930.xsd EX-101.SCH 38688
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mygn-20250930_cal.xml EX-101.CAL 63755
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mygn-20250930_def.xml EX-101.DEF 114932
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mygn-20250930_lab.xml EX-101.LAB 521087
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mygn-20250930_pre.xml EX-101.PRE 340522
79 EXTRACTED XBRL INSTANCE DOCUMENT mygn-20250930_htm.xml XML 762105
Mailing Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116
Business Address 322 NORTH 2200 WEST SALT LAKE CITY UT 84116 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26642 | Film No.: 251446280
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)